Canada Clinical Trial Imaging Market Size & Outlook
Related Markets
Canada clinical trial imaging market highlights
- The Canada clinical trial imaging market generated a revenue of USD 58.9 million in 2024 and is expected to reach USD 86.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 6.8% from 2025 to 2030.
- In terms of segment, computed tomography scan was the largest revenue generating modality in 2024.
- Magnetic Resonance Imaging is the most lucrative modality segment registering the fastest growth during the forecast period.
Clinical trial imaging market data book summary
| Market revenue in 2024 | USD 58.9 million |
| Market revenue in 2030 | USD 86.7 million |
| Growth rate | 6.8% (CAGR from 2025 to 2030) |
| Largest segment | Computed tomography scan |
| Fastest growing segment | Magnetic Resonance Imaging |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Computed Tomography Scan, Magnetic Resonance Imaging, X-Ray, Ultrasound, Optical Coherence Tomography (OCT), Other Modalities |
| Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
Other key industry trends
- In terms of revenue, Canada accounted for 4.8% of the global clinical trial imaging market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. clinical trial imaging market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 675.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Imaging Market Scope
Clinical Trial Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Resonance Health | View profile | 1-10 | Claremont, Western Australia, Australia, Oceania | http://resonancehealth.com |
| Intrinsic Imaging | View profile | 51-100 | Bolton, Massachusetts, United States, North America | http://www.intrinsicimaging.com |
| Cardiovascular Imaging Technologies | View profile | - | Kansas City, Missouri, United States, North America | https://www.cvit.com |
| ProScan Imaging | View profile | 251-500 | Cincinnati, Ohio, United States, North America | http://www.proscan.com/ |
| Clario | View profile | 5001-10000 | Philadelphia, Pennsylvania, United States, North America | https://clario.com/ |
| Ixico | View profile | 51-100 | London, England, United Kingdom, Europe | http://www.ixico.com |
| BioTelemetry | View profile | 1001-5000 | Malvern, Pennsylvania, United States, North America | https://www.gobio.com |
| Navitas Organics | View profile | 51-100 | Novato, California, United States, North America | https://navitasorganics.com/ |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
Canada clinical trial imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Computed tomography scan was the largest segment with a revenue share of 27.5% in 2024. Horizon Databook has segmented the Canada clinical trial imaging market based on computed tomography scan, magnetic resonance imaging, x-ray, ultrasound, optical coherence tomography (oct), other modalities covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical trial imaging market in Canada is expected to grow significantly over the forecast period. The Health Canada manages the clinical trial database and provides a source of information about clinical trials in the country. Health Canada is the federal regulator accountable for authorizing the importation and sales of drugs for clinical trials.
This accountability is achieved by reviewing clinical trial applications for Phase I to III clinical trials, filed by sponsors of clinical trials. One of the objectives of Health Canada’s review is to determine that subjects contributing to the trial will not be exposed to unnecessary risks.
Health Canada approves nearly 900 clinical trials every year. Canada is known for the quality & expertise of its research clinicians. Most of them are universally recognized for key innovations & discoveries in the medical field and the ability to perform clinical research in difficult therapeutic areas with a large population base.
Reasons to subscribe to Canada clinical trial imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada clinical trial imaging market databook
-
Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Canada clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada clinical trial imaging market size, by modality, 2018-2030 (US$M)
Canada Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
